Cytek Biosciences Files Definitive Proxy Statement
Ticker: CTKB · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1831915
| Field | Detail |
|---|---|
| Company | Cytek Biosciences, Inc. (CTKB) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, regulatory-filing
Related Tickers: CTK
TL;DR
Cytek (CTK) proxy filed. Annual meeting June 18. Vote your shares!
AI Summary
Cytek Biosciences, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting on June 18, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company is based in Fremont, CA, and operates in the laboratory analytical instruments sector.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting, including any proposals or director elections, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information for an upcoming shareholder meeting, not indicating new financial risks or operational changes.
Key Players & Entities
- Cytek Biosciences, Inc. (company) — Registrant
- 47215 LAKEVIEW BOULEVARD (address) — Business and Mail Address
- FREMONT (location) — City
- CA (location) — State
- 94538 (zip_code) — Zip Code
- 001-40632 (sec_file_number) — SEC File Number
- 25880639 (film_number) — Film Number
- 20250428 (date) — Filing Date
- 20250618 (date) — Period of Report / Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information and solicit their proxies for the upcoming annual meeting of Cytek Biosciences, Inc. on June 18, 2025.
When was this definitive proxy statement filed with the SEC?
This definitive proxy statement was filed with the SEC on April 28, 2025.
What is Cytek Biosciences, Inc.'s primary business classification?
Cytek Biosciences, Inc. is classified under 'LABORATORY ANALYTICAL INSTRUMENTS' with SIC code 3826.
Where is Cytek Biosciences, Inc. headquartered?
Cytek Biosciences, Inc. is headquartered at 47215 LAKEVIEW BOULEVARD, FREMONT, CA 94538.
Is there a filing fee associated with this proxy statement?
No fee is required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Cytek Biosciences, Inc. (CTKB).